Browsing Category

Articles

Banking Featured News Infographics Past Conference Uncategorized Upcoming conference Webinar

Articles

Navigating the Future: Key IT Trends in Financial Services

Admin Oct 17, 2024

Financial institutions are increasingly leveraging advanced IT solutions to enhance their operations, improve…

Articles

The Problem of Excess Inventory

Admin Jun 26, 2024

One of the most notable ramifications of the growth of e-commerce on the retail sector has been a spike in…

Newer Posts

Lanier Recovery Center launches virtual IOP for adults across Georgia

2026-09-26T14:00:00Z

Joint Commission-accredited outpatient program in Suwanee expands access to structured addiction treatment for people who can't attend in person

Chrysalis Health and Curaechoice Join Forces to Address Cost and Access Barriers to Mental Health Care

2026-09-25T22:54:00Z

Strategic collaboration expands no-cost access to trusted in-person and virtual mental health services, helping employers simplify care while improving affordability and access for employees and their families.

Global Health Congress 2026 Convenes Health System Leaders, Clinicians, Technologists, Investors and Innovators at the Yale Club of New York City, October 9th-11th

2026-09-25T21:49:16Z

The three-day congress features keynote speaker Robert Herjavec and a live Venture Forum where healthcare founders pitch to investors and strategic partners.

Microbot Medical® Highlights Growth Strategy

2026-09-25T21:30:00Z

User Survey Demonstrates High Satisfaction of the LIBERTY System

Family-Owned Canadian Supplement Brand Herba Ranks No. 81 on The Globe and Mail’s List of Canada’s Top Growing Companies

2026-09-25T21:19:00Z

With over 100 Canadian-made supplements, Herba earns its second consecutive appearance and ranks No. 9 in the Health Care & Wellness category.

Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency

2026-09-25T21:00:00Z

SAN DIEGO, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced...

Quest PharmaTech Announces Change of Chief Executive Officer

2026-09-25T21:00:00Z

EDMONTON, Alberta, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life...

BioAge Labs to Present at Upcoming Investor Conferences

2026-09-25T20:30:00Z

EMERYVILLE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for cardiometabolic diseases by targeting the...

NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments

2026-09-25T20:30:00Z

VANCOUVER, British Columbia, Sept. 25, 2026 (GLOBE NEWSWIRE) -- NervGen (NASDAQ: NGEN), a late-stage clinical biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and...

Crescent Biopharma Announces Grants of Inducement Awards

2026-09-25T20:15:00Z

WALTHAM, Mass., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies...

Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR

2026-09-25T17:05:00Z

Data presented at the AACR Conference on Pancreatic Cancer indicate Annamycin’s antitumor activity is partially mediated by CD8+ T cells, supporting a potential immune-mediated mechanism alongside its direct cytotoxic activity

SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer

2026-09-25T17:00:00Z

NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel...

Orion Corporation: Acquisition of own shares during week 39, 2026

2026-09-25T16:00:00Z

Orion Corporation: Acquisition of own shares during week 39, 2026

OneMedNet Corporation Announces 1-for-10 Reverse Stock Split

2026-09-25T15:50:00Z

MINNEAPOLIS, Sept. 25, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “Company,” “we,” or “our”), a leading provider of first-party (direct-from-source) regulatory decision-grade, AI-driven Real-World Data (RWD), today announced...

Newron Provides Update on Phase 3 ENIGMA-TRS 2 Study

2026-09-25T15:45:00Z

Ad hoc announcement pursuant to Art. 53 LR

Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS

2026-09-25T14:30:00Z

Leiden, the Netherlands, September 25, 2026: Pharming (Euronext Amsterdam: PHARM/Nasdaq: PHAR), a global biotechnology company focused on rare immune and genetic diseases, today announced that the U.S. Food and Drug Administration (FDA) has...

BioSyent Named as One of Canada’s Top Growing Companies 2026 by The Globe and Mail

2026-09-25T13:37:47Z

MISSISSAUGA, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that it has been named as one of Canada’s Top...

Fangzhou Releases 2026 Interim Report, Deepening "AI + Chronic Care" as a Lifetime Health Service Partner

2026-09-25T13:33:56Z

SHANGHAI, China, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, has released its 2026 interim report,...

Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026

2026-09-25T13:05:20Z

Company to feature surgeon-led educational programming and technologies supporting liver surgery

Kraig Labs’ Atlas Milestone Opens the Door to Potential Historic Spider Silk Advancements

2026-09-25T13:04:51Z

DENVER, Sept. 25, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- A completed library of living genetic building blocks positions Kraig Biocraft Laboratories (OTCQB: KBLB) to explore more than 200 potential configurations...

SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026

2026-09-25T13:00:00Z

IRVINE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a...

Tilray Brands to Announce First Quarter Fiscal Year 2027 Financial Results on October 8, 2026

2026-09-25T13:00:00Z

NEW YORK and LONDON and LEAMINGTON, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged...

INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference

2026-09-25T13:00:00Z

SARASOTA, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of...

Knowtex, the First Frontier AI Lab for Healthcare, Named Prime Awardee on VA's Nine-Figure Ambient Scribe Enterprise Contract

2026-09-25T13:00:00Z

One of two prime awardees on the $775.72 million multiple-award IDIQ, Knowtex is expanding AI that gives clinicians more time with Veterans. It's already live at 79 VA medical centers...

Teladoc Health Announces Chief Legal Officer Transition

2026-09-25T12:30:00Z

Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026

CDT Equity Inc. Announces Reverse Stock Split

2026-09-25T12:10:00Z

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Sept. 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), announces that its board of directors has approved a...

Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure

2026-09-25T12:03:01Z

Definition requires five years off myeloma treatment with sustained MRD negativity, assessed with technology sensitive enough to identify one myeloma cell among one million cells

neurocare and Wave Neuroscience partner to expand patient access to FDA-Cleared MeRT® therapy for PTSD on the Apollo TMS Therapy System

2026-09-25T12:00:00Z

Munich, Germany and Alpharetta, GA, United States, September 25, 2026 - neurocare group AG (“neurocare” or the “Company”), a best practice platform for mental health and performance, and the company...

Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD

2026-09-25T11:45:00Z

– Partnership will introduce NeuroSigma’s second-generation Monarch eTNS® System to Firefly’s nationwide network of Evoke™ clinicians –

Cerenome to Hold CNSide® Business Update Call on September 30, 2026

2026-09-25T11:30:00Z

Management to provide updates on recent developments including diagnostic billing, market access & growth plans

India’s Fintech Market Crash: Is the Boom Turning Into a Reality Check?

Can Blockchain Revolutionize the Banking System?

FinTech and Employee F&F Settlement: How Digital Financial…

How AI and Digital Innovation Are Transforming the Future of the…

Articles

Navigating the Future: Key IT Trends in Financial Services

The Problem of Excess Inventory